These observations are highly significant because they uncover a previously undocumented genetic vulnerability that is pharmacologically amenable and can be targeted to treat NRAS-mutant melanoma.
← all excerpts
Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth.
1
—
—